Time course of various inflammatory mediators during recurrent endotoxemia.

[1]  P. Heinrich,et al.  Hemodynamic variables and plasma levels of PGI2, TXA2 and IL-6 in a porcine model of recurrent endotoxemia. , 1991, Circulatory shock.

[2]  P. Heinrich,et al.  Time course of IL-6 and TNFα release during endotoxin-induced endotoxin tolerance in rats , 1991 .

[3]  Schwartz Lw,et al.  Therapeutic intervention in a rat model of adult respiratory distress syndrome: III. Cyclooxygenase pathway inhibition. , 1991 .

[4]  R. Dobrowsky,et al.  Effect of SRI 63-675 on hemodynamics and blood PAF levels during porcine endotoxemia. , 1991, The American journal of physiology.

[5]  J V Castell,et al.  Interleukin-6 and the acute phase response. , 1990, The Biochemical journal.

[6]  K. Glaser,et al.  Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. , 1989, The Journal of biological chemistry.

[7]  N. Christou,et al.  Endotoxin tolerance is associated with reduced secretion of tumor necrosis factor. , 1989, Archives of surgery.

[8]  J. Vilček,et al.  IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. , 1989, Journal of immunology.

[9]  L. G. Thijs,et al.  Increased plasma levels of interleukin-6 in sepsis [see comments] , 1989 .

[10]  T. Hugli,et al.  Endotoxin-induced shock in the rat. A role for C5a. , 1989, The American journal of pathology.

[11]  S. Zuckerman,et al.  Endotoxin-macrophage interaction: post-translational regulation of tumor necrosis factor expression. , 1989, Journal of immunology.

[12]  T. Kishimoto,et al.  The biology of interleukin-6. , 1989, Blood.

[13]  A. Cross,et al.  Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection , 1989, The Journal of experimental medicine.

[14]  R. Demling,et al.  Relationship between lung injury and lung lipid peroxidation caused by recurrent endotoxemia. , 1989, The American review of respiratory disease.

[15]  L. Aarden,et al.  Comparison of the effects of recombinant interleukin 6 and recombinant interleukin 1 on nonspecific resistance to infection , 1989, European journal of immunology.

[16]  J. Norton,et al.  Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity , 1988, The Journal of experimental medicine.

[17]  R. Ulevitch,et al.  Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. , 1988, The Journal of clinical investigation.

[18]  T. Hirano,et al.  Induction of rat acute‐phase proteins by interleukin 6 in vivo , 1988, European journal of immunology.

[19]  D. Herndon,et al.  Cardiopulmonary responses to continuous administration of endotoxin. , 1988, The American journal of physiology.

[20]  J. Schneider.  Salutary effects of the prostacyclin analogue CG 4203 in lethal endotoxemia in rats. , 1988, Prostaglandins, leukotrienes, and essential fatty acids.

[21]  C. Dinarello,et al.  Biology of interleukin 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  A. Waage.  Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone. , 1987, Clinical immunology and immunopathology.

[23]  A. Wendel,et al.  Evidence for the involvement of a reperfusion injury in galactosamine/endotoxin-induced hepatitis in mice. , 1987, Biochemical pharmacology.

[24]  N. Voelkel,et al.  Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. , 1987, The Journal of clinical investigation.

[25]  R. Demling,et al.  The pulmonary and systemic response to recurrent endotoxemia in the adult sheep. , 1986, Surgery.

[26]  D. Handley,et al.  Inhibition and reversal of endotoxin-, aggregated IgG- and paf-induced hypotension in the rat by SRI 63-072, a paf receptor antagonist. , 1986, Immunopharmacology.

[27]  B. Beutler,et al.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. , 1985, Science.

[28]  F. Barrett,et al.  ENDOTOXIN LIBERATION DURING THERAPY FOR GRAM-NEGATIVE BACTERIAL SEPSIS , 1985 .

[29]  Margaret S. Wu,et al.  Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. , 1985, Biochemical and biophysical research communications.

[30]  S. Sumida,et al.  Is platelet activating factor (PAF) a mediator of endotoxin shock? , 1985, European journal of pharmacology.

[31]  A. Beyer,et al.  Endogenous prostaglandin F2α in the hyperdynamic state of severe sepsis in man , 1983 .

[32]  L. Myatt,et al.  A comparison of the quantitative analysis of 6-oxo-PGF1 alpha in biological fluids by gas chromatography mass spectrometry and radioimmunoassay. , 1981, Biomedical mass spectrometry.

[33]  M. Gee,et al.  Pulmonary injury and prostaglandin production during endotoxemia in conscious sheep. , 1981, The American journal of physiology.

[34]  B. Samuelsson,et al.  Radioimmunoassay for Thromboxane B2 , 1976 .

[35]  R. L. West,et al.  Blood coagulation factor activity in experimental endotoxemia. , 1966, Annals of surgery.

[36]  R. Tompkins,et al.  Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. , 1990, The Journal of infectious diseases.

[37]  A. M. Lefer,et al.  Significance of lipid mediators in shock states. , 1989, Circulatory shock.

[38]  C. Wahlen,et al.  A comparison of Escherichia coli endotoxin single bolus injection with low-dose endotoxin infusion on pulmonary and systemic vascular changes. , 1987, Circulatory shock.

[39]  P. Lansdorp,et al.  Production of hybridoma growth factor by human monocytes , 1987, European journal of immunology.

[40]  D. Männel,et al.  The Role of Post-Endotoxin Serum Components from BCG Infected Mice in the Protection of Compromised Hosts , 1986 .

[41]  C. Lang,et al.  Regional blood flow during continuous low-dose endotoxin infusion. , 1986, Circulatory shock.

[42]  Spitzer Ja,et al.  Continuous infusion of endotoxin from an osmotic pump in the conscious, unrestrained rat: a unique model of chronic endotoxemia. , 1984 .

[43]  T. Chard,et al.  introduction to radioimmunoassay and related techniques , 1982 .